Remlifanserin

A serotonin receptor antagonist

Remlifanserin
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Remlifanserin is a chemical compound that acts as a selective antagonist of the serotonin 5-HT_2A receptor. It was initially developed for the treatment of schizophrenia and other psychotic disorders.

Pharmacology

Remlifanserin is known for its high affinity for the 5-HT_2A receptor, where it functions as an antagonist. This means that it binds to the receptor and inhibits its action, which can modulate the effects of serotonin in the brain. The 5-HT_2A receptor is implicated in various neurological processes, including mood regulation, perception, and cognition.

Mechanism of Action

The primary mechanism of action of Remlifanserin involves blocking the 5-HT_2A receptors. By inhibiting these receptors, Remlifanserin can potentially reduce symptoms associated with psychotic disorders, such as hallucinations and delusions. The modulation of serotonin activity is thought to contribute to its antipsychotic effects.

Development and Research

Remlifanserin was developed in the late 20th century as part of efforts to create new treatments for schizophrenia. Although it showed promise in preclinical studies, its development was eventually discontinued. The reasons for discontinuation often include lack of efficacy in clinical trials, safety concerns, or strategic business decisions by the developing company.

Potential Applications

While Remlifanserin is not currently used in clinical practice, its pharmacological profile suggests potential applications in treating disorders characterized by dysregulation of serotonin, such as depression, anxiety disorders, and bipolar disorder. However, further research would be necessary to explore these possibilities.

Chemical Properties

Remlifanserin is chemically classified as an indole derivative. Its structure includes a piperazine ring, which is a common feature in many psychotropic drugs. The presence of a chlorophenyl group contributes to its binding affinity for the 5-HT_2A receptor.

Related Pages

• Serotonin receptor antagonist
• 5-HT2A receptor
• Schizophrenia
• Psychotic disorders